Novavax faces uncertainty as FDA requests a new clinical trial for its COVID-19 vaccine, the last protein-based option in the ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Wall Street analysts expect Moderna (MRNA) to post quarterly loss of $2.92 per share in its upcoming report, which indicates a year-over-year increase of 4.9%. Revenues are expected to be $126.98 ...

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading this week, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...

Shares of NASDAQ MRNA opened at $24.50 on Wednesday. Moderna has a 52-week low of $23.15 and a 52-week high of $170.47. The business has a fifty day moving average of $31.72 and a two-hundred day ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...

Moderna sued Pfizer and BioNTech for infringing three of Moderna’s patents directed to mRNA and lipid technology. While Pfizer and BioNTech did not file any counterclaims for patent infringement ...

The surprise delay is casting new uncertainty on the fate of another vaccine awaiting FDA action: Moderna’s next-generation Covid-19 shot, called mRNA-1283, which is set for a decision by May 31.

CAMBRIDGE, MA - Moderna Inc (BMV:MRNA). (NASDAQ:MRNA) is set to present a series of scientific studies at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global ...

Schroder Investment Management Group lessened its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 76.3% during the 4th quarter, according to its most recent filing with the ...